11.07.2015 Views

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PrefaceThis third <strong>ed</strong>ition <strong>of</strong> the <strong>Clinical</strong> <strong>Textbook</strong> <strong>of</strong> <strong>Addictive</strong> <strong>Disorders</strong> appears 20years after the founding <strong>of</strong> the American Academy <strong>of</strong> Addiction Psychiatry(AAAP). During this period, major progress has occurr<strong>ed</strong> in both general psychiatryand addiction psychiatry. There has been movement ranging fromdescription <strong>of</strong> the phenomenology <strong>of</strong> psychiatric disorders, including substanceuse disorders (SUDs), to the beginnings <strong>of</strong> understanding neurobiologicalmechanisms, pathophysiology, genetic and family influences, and etiology.Addiction treatment research, including that for comorbid conditions, hasadvanc<strong>ed</strong> and the development <strong>of</strong> evidence-bas<strong>ed</strong> guidelines for addictiontreatment has been launch<strong>ed</strong>. While treatment methods are still very much ti<strong>ed</strong>to the craft and art <strong>of</strong> psychotherapy (including self-help and spirituality), dissemination<strong>of</strong> research findings and evidence-bas<strong>ed</strong> treatment approaches willadd to the quality <strong>of</strong> care <strong>of</strong> patients.Unfortunately, our advances in the understanding <strong>of</strong> addiction psychiatryare not necessarily associat<strong>ed</strong> with r<strong>ed</strong>uctions in the incidence <strong>of</strong> substance use.The magnitude <strong>of</strong> use seems to be subject to fads and fluctuations in perceptions<strong>of</strong> risk <strong>of</strong> use. Over the past 30 years there have been important variationsin the use <strong>of</strong> substances by age, gender, ethnic, and racial groups. The mostrecent estimate on the cost <strong>of</strong> substance use is for 1998, with the cost <strong>of</strong> drugabuse directly estimat<strong>ed</strong> at $143.4 billion (Office <strong>of</strong> National Drug Control Policy,2001) and the costs <strong>of</strong> alcohol abuse project<strong>ed</strong> to be $185 billion(Harwood, 2000). This figure (estimat<strong>ed</strong> in 1992) reflects the estimat<strong>ed</strong> 8.3%<strong>of</strong> the population ages 12 or older who were current illicit drug users in 2002and perhaps also includes the 2.6% <strong>of</strong> the population ages 12 or older who werecurrent users <strong>of</strong> psychotherapeutic drugs taken nonm<strong>ed</strong>ically in 2002. The rate<strong>of</strong> current drug use among adolescents in 2002 was 11.6%, but that rate was surpass<strong>ed</strong>by young adults (ages 18–25 years) at 20.2%. As for alcohol, an estimat<strong>ed</strong>120 million Americans ages 12 or older report<strong>ed</strong> being current drinkersxi

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!